Efficacy and safety of dofetilide and sotalol in patients with hypertrophic cardiomyopathy

Abstract Background Professional society practice guidelines conflict regarding their recommendations of dofetilide (DOF) and sotalol (STL) for treatment of arrhythmias in hypertrophic cardiomyopathy (HCM), and supporting data is sparse. We aim to assess safety and efficacy of DOF and STL on arrhyth...

Full description

Bibliographic Details
Main Authors: Chris Chen, Mallika Lal, Yunwoo Burton, Hongya Chen, Eric Stecker, Ahmad Masri, Babak Nazer
Format: Article
Language:English
Published: Nature Portfolio 2023-07-01
Series:Communications Medicine
Online Access:https://doi.org/10.1038/s43856-023-00315-8